Build vs. Buy Synthetic Wealth Data — Decision Tree
The build-vs-buy decision for synthetic wealth data isn't about cost — it's about depth and cadence. A team that nails the demographic distribution but skips the regulatory tracking ships a corpus that ages quickly. This decision tree branches on the four inputs that actually move the answer.
What you walk away with
~2 min · 2 questions · 4 possible outcomes- A specific 'build' / 'buy' / 'hybrid' recommendation.
- A one-paragraph rationale anchored on your binding constraint.
- Linked artifacts (ROI worksheet, in-house comparison, Master Corpus) for the decision write-up.
How much vertical wealth-tech depth does your team have on staff?
FAQ
What if we already started building in-house?
Score the existing corpus with the Wealth-Tech Test-Data Maturity Assessment first. If you're at 'Defined' or 'Managed,' a hybrid contract is often the highest-leverage path; if you're at 'Ad Hoc,' starting fresh with WealthSynth is usually faster than remediating in place.
Is the recommendation different for different products?
Yes. Robo-advisor and Reg BI-touching products favor 'buy' more strongly because the regulatory tracking burden is highest there. Internal-only / pre-launch products tolerate more in-house build.